Physician profile
Dwight Tiu
NPI 1154326585
$816.31
in general payments reported to CMS, 2019-2025
9 companies · $24.60 in 2025
The $24.60 reported for 2025 was less than what a typical Addiction Medicine (Family Medicine) provider received nationally (typical 2025 total: $143).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $157 · 2021: $39.18 · 2022: $188 · 2023: $73.46 · 2024: $333 · 2025: $24.60.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Debt Forgiveness: $333 · Food and Beverage: $98.06.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Debt Forgiveness | $333.34 |
| Food and Beverage | $98.06 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Photonicare INC | $374.32 | 2023-2024 | Otosight Middle Ear Scope |
| Pfizer INC. | $142.43 | 2019-2021 | |
| Corium, LLC | $126.23 | 2022 | |
| Merck Sharp & Dohme LLC | $54.57 | 2022-2023 | Vaxneuvance, Gardasil 9 |
| Sanofi Pasteur INC. | $39.97 | 2022-2023 | |
| Glaxosmithkline, LLC. | $38.74 | 2021-2025 | Bexsero |
| Phadia US INC. | $14.82 | 2019 | |
| Orexo US, INC. | $12.75 | 2019 | |
| Ironshore Pharmaceuticals INC. | $12.48 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Dwight Tiu listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.